CD147: A Novel Modulator of Inflammatory and Immune Disorders

E-ISSN： 1875-533x|21|19|2138-2145

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.19, 2014-06, pp. : 2138-2145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders

Current Drug Targets, Vol. 13, Iss. 6, 2012-05 ,pp. : 842-862

Bentham Science Publishers

Access to resources Recommend Favorite

CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune Disorders

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 3, 2007-03 ,pp. : 253-273

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Recent Advances in Anti-Inflammatory and Immune-Modulator Drugs Development and Analytical Tools for Their Characterization)

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 11, Iss. 1, 2012-06 ,pp. : 2-2

Bentham Science Publishers

Access to resources Recommend Favorite

Lactoferrin as a Natural Immune Modulator

Current Pharmaceutical Design, Vol. 15, Iss. 17, 2009-01 ,pp. : 1956-1973

Bentham Science Publishers

Access to resources Recommend Favorite

TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 4, 2007-12 ,pp. : 223-235

Bentham Science Publishers

Access to resources Recommend Favorite